COCH Envoy Medical, Inc. Class A Common Stock Loading... : Investor Sentiment and Bull/Bear Views
Loading chart...
Top Calls
No data yet
Price change since each call, adjusted for long/short direction. Results calculated:
Feed
20:59
Feb 12
Feb 12
COCH long on FDA 2027 and listing catalyst
The author argues COCH raised $30M via an S-1A filing and will meet the February 23 requirement, with the CEO incentivized to push the stock to $1 by May via 200k options at $0.53. They expect FDA approval in 2027 to make the company worth at least $500M, implying a fair price of $15. The author claims the stock is being heavily manipulated like prior names RANI, SCNX, and VTYX, and should be at least $4 now. Main risk is the heavy manipulation and the binary FDA approval timeline.
MED
About COCH Investor Commentary
Across the available history and selected sources, Buzzberg tracks COCH (Envoy Medical, Inc. Class A Common Stock) across 1 sources: 1 bullish vs 0 bearish calls from 1 authors. Historical directional balance: 100% = 100 × (bullish − bearish) / all deduplicated idea records, including other directions. This is neither a probability of a price rise nor the share of bullish authors. 1 total trade idea tracked. Latest voices: u/Spirited_Profile4499.